T2 Biosystems to Present at the Needham Healthcare Conference
March 28 2017 - 6:30AM
T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John
McDonough, president and chief executive officer, is scheduled to
attend and present at the Needham Healthcare Conference on
Wednesday, April 5, 2017 at 11:20am ET at the Westin New York Grand
Central Hotel in New York City.
A live, listen-only webcast of the presentation may be accessed
by visiting the Events & Presentations section of the Company’s
website at www.t2biosystems.com under Investors. A replay of
the webcast will be available shortly after the conclusion of the
presentation and will be archived on the Company's website for 90
days following the presentation.
About T2 BiosystemsT2 Biosystems is focused on
developing innovative diagnostic products to improve patient
health. With the FDA-cleared T2Dx® Instrument and T2Candida® Panel
targeting sepsis and a range of additional products in development,
T2 Biosystems is an emerging leader in the field of in vitro
diagnostics. The Company is utilizing its proprietary T2 Magnetic
Resonance platform, or T2MR®, to develop a broad set of
applications aimed at lowering mortality rates, improving patient
outcomes and reducing the cost of healthcare by helping medical
professionals make targeted treatment decisions earlier. T2MR
enables the fast and sensitive detection of pathogens, biomarkers
and other abnormalities in a variety of unpurified patient sample
types, including whole blood, eliminating the time-consuming sample
prep required in current methods. For more information, please
visit www.t2biosystems.com.
Media Contact:
Matthew McKillip, T2 Biosystems
mmckillip@t2biosystems.com
518-577-3466
Investor Contact:
Tucker Elcock, Teneo Strategy
Tucker.Elcock@teneostrategy.com
212-886-9319
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Aug 2024 to Sep 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Sep 2023 to Sep 2024